Market Signal Briefing

Key Takeaways Silox to acquire BASF's hydrosulfite-related IP, special containers, equipment and trademarks.BASF will discontinue hydrosulfite production at Ludwigshafen as part of its strategic portfolio review.The deal strengthens Silox's position in sodium hydrosulfite reducing and bleaching agents. BASF SE (BASFY - Free Report) has signed a definitive agreement to divest hydrosulfite-related assets to Silox. The transaction includes intellectual property rights, special containers, selected production equipment, technical expertise and associated trademarks in the company’s hydrosulfite business.

The deal follows BASF’s earlier decision announced in September 2025 to discontinue hydrosulfite production at its Ludwigshafen Site as part of a strategic portfolio review. By divesting these assets, BASF will streamline its portfolio while focusing on other inorganic chemicals produced at the Ludwigshafen plant, including alcoholates, sulfites and nitrogen salts.

The acquisition will strengthen Silox’s position as a leading producer of sodium hydrosulfite-based reducing and bleaching agents. With more than 70 years of expertise and production facilities in Belgium, India and Canada, the company emerges as a trusted partner in the global market. As hydrosulfites play a crucial role in various industrial applications, particularly as reducing agents in textile dyeing and as bleaching additives in pulp and paper production.

Silox Group, through the acquisition, reinforces its long-term commitment to the textile and paper industries. The agreement also reflects BASF’s strategy of prioritizing portfolio optimization.

BASFY stock has slumped 5.2% over the past year compared with the industry’s 8.3% decline.

Image Source: Zacks Investment Research

BASFY’s Zacks Rank & Key PicksBASFY currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the Basic Materials space are Agnico Eagle Mines Limited (AEM - Free Report) ,Compañía de Minas Buenaventura S.A.A. (BVN - Free Report) and Balchem Corporation (BCPC - Free Report) .

While AEM and BVN sport a Zacks Rank #1 (Strong Buy) each at present, BCPC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for AEM’s 2026 earnings is pegged at $13.28 per share, indicating a rise of 60.39% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 10.77%. AEM’s shares have soared 127.8% over the past year.

The Zacks Consensus Estimate for BVN’s 2026 earnings is pinned at $3.88 per share, indicating a 17.58% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 80.4%. BVN’s shares have jumped 183.9% over the past year.

The Zacks Consensus Estimate for BCPC’s 2026 earnings is pinned at $5.47 per share, indicating a 6.2% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the four trailing quarters, while missing it in the remaining two. BCPC’s shares have gained 2.7% over the past year.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - March 10, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zynex, Inc. ("Zynex" or the "Company") (OTC Pink: ZYXIQ) and reminds investors of the April 21, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (a) Zynex shipped products, including electrodes, in excess of need; (b) as a result of this practice, the Company inflated its revenue; (c) the Company's practice of filing false claims drew scrutiny from insurers, including Tricare; (d) on August 21, 2023, Travelers commenced an action against Zynex, Sandgaard, Lucsok and Fox in the Superior Court of California alleging that Zynex and the defendants had embarked on a fraudulent overbilling scheme and sought more than $23 million in damages and civil penalties relating to hundreds of fraudulent claims between 2018 and 2023; (e) management had prioritized aggressive sales strategies to drive orders over compliance with industry laws, rules and regulations; (f) the Company was not committed to maintaining a strong internal control environment; (g) the Company's order growth was a result of illegal overbilling; (h) as a result, it was reasonably likely that Zynex would face adverse consequences, including removal from insurer networks and penalties from the federal government; and (i) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On March 11, 2025, after the market closed, Zynex reported its fourth quarter and full year 2024 financial results, revealing a significant revenue "shortfall" in the quarter "due to slower than normal payments from certain payers." Zynex further revealed "Tricare has temporarily suspended payments as they review prior claims." Tricare is the health insurance program for the U.S. military, and Zynex's largest customer, accounting for 20-25% of revenue.

On this news, Zynex's stock price fell $3.59 per share, or 51.3%, to close at $3.41 per share on March 12, 2025, on unusually heavy trading volume.

Then, on July 31, 2025, the full extent of Defendants' misdeeds were revealed when the Company acknowledged that it had not been in compliance with industry regulations. Also that day, the Company remarked on the "transformational" leadership change during the quarter with the appointment of new Chief Executive Officer ("CEO") Steven Dyson ("Dyson") to replace Sandgaard, and the announced departure of the Company's Chief Financial Officer ("CFO") Daniel Moorhead ("Moorhead"). The Company also temporarily suspended revenue and profitability guidance.

On August 1, 2025, the stock fell from the previous day's $2.23 per share to $1.26 per share, a 45% decline in heavy trading volume.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Zynex's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Zynex, Inc. class action, go to www.faruqilaw.com/ZYXIQ or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/287960

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Kohl's Corporation (NYSE:KSS) shares climbed about 3.8% on Tuesday after the department store chain reported fourth-quarter earnings that topped Wall Street expectations, even as comparable store sales lagged estimates.

The company posted Q4 net income of $125 million, or $1.07 per share, beating analysts’ average forecast of $0.86.

Revenue fell 3.9% year-over-year to $4.97 billion, slightly below the $5.02 billion consensus. Comparable store sales declined 2.8%, missing the 1.5% drop analysts had predicted.

Kohl’s gross margin improved 25 basis points from a year earlier to 33.1%, aided by better inventory management despite rising shipping costs. Operating income rose 5% to $212 million, while operating cash flow came in at $750 million. Inventory declined 7% year-over-year to $2.7 billion.

“Despite missing top-line and comp expectations, the earnings beat underscores the company’s continued focus on margin management and operational efficiency,” Jefferies analysts wrote in a note.

For fiscal 2026, Kohl’s expects adjusted EPS between $1 and $1.60, below the $1.37 consensus midpoint. The company anticipates comparable sales will range from a 2% decline to flat, also below Street expectations.

Adjusted operating margin is projected at 2.8% to 3.4%, with capital expenditures of $350 million to $400 million. The retailer will maintain a quarterly dividend of $0.125 per share.

Kohl’s faces challenges during peak holiday periods as competitors boost value offerings and consumers continue shifting toward e-commerce, the company said. Management flagged that it lost market share during Black Friday, Cyber Monday, and the week following Christmas and plans to adjust promotions to better align with value-conscious shoppers.

Looking ahead, Jefferies analysts are focused on monthly performance trends, holiday sales insights, tariff impacts on pricing and margins, and category-specific results, particularly fashion versus basics and private-label versus branded products.

Key Takeaways Photonics companies sell the picks & shovels to the AI revolution.Demand is outpacing traditional copper wiring, allowing photonics to take center stage.Market leadership is being validated by institutional and corporate action. Understanding “Picks and Shovels” InvestmentsDuring the California Gold Rush of the mid-1800s, the term “picks and shovels” became prominent. In the case of the Gold Rush, picks-and-shovel plays included Levi ((LEVI - Free Report) ) jeans and, as the name implies, the tools for mining gold. Since the gold rush, pick and shovel plays have proven that they often make for gold miner optimal investments.

For instance, regardless of whether one gold miner or another struck it rich, each get-rich adventurer needs jeans and tools to even attempt to mine gold. More recently, discount stockbroker Robinhood (HOOD) is a perfect example of a pick-and-shovel play. The company and its stock have benefited tremendously because, regardless of whether specific stocks rise or fall, it makes money from payment for order flow.

Photonics: The “Picks and Shovels” of the AI RevolutionOne relatively obscure technology is quickly becoming the pick-and-shovel investment opportunity of the artificial intelligence (AI) revolution: photonics. Photonics is the science of generating, controlling, and manipulating light (photons). As AI computing demands grow (which they will), traditional copper wiring for data transfer is becoming a bottleneck due to heat and speed constraints.

In the AI infrastructure cycle, investors first piled into semiconductor makers like NVIDIA ((NVDA - Free Report) ), then cooling/power systems. Currently, the biggest bottleneck in the burgeoning industry is network and communication speed. Regardless of how fast the chips are, if the optimal networks carrying the data are suboptimal, the system gets clogged. Companies such as Coherent ((COHR - Free Report) ), Lumentum ((LITE - Free Report) ), and Applied Optoelectronics ((AAOI - Free Report) ) manufacture the technology to de-clog AI networks.

The AI-Build Out Isn’t SlowingOne of the biggest misconceptions on Wall Street in 2026 is that AI spending is slowing. Although AI-related CAPEX spending is already unprecedented, according to Bloomberg research and guidance from hyperscalers like Alphabet ((GOOGL - Free Report) ) and Microsoft ((MSFT - Free Report) ), it’s only going to grow. CAPEX spending from the hyperscalers Microsoft, Alphabet, Amazon ((AMZN - Free Report) ), Meta Platforms ((META - Free Report) ), and Oracle ((ORCL - Free Report) ) is expected to jump from $390 billion in 2025 to $515 billion in 2026 and to a mind-boggling $729 billion in 2027!

Image Source: Carson Investment Research

Remember, unlike the hyperscalers, photonics stocks benefit from AI spending regardless of ROI on large language models like Gemini and ChatGPT.

Lumentum’s Earnings Are Expected to SoarThe key ingredient for a winning growth stock is robust top-and-bottom-line growth. Lumentum, for example, grew revenue by 65% and earnings-per-share (EPS) by a juicy 298% year-over-year. Meanwhile, Zacks Consensus Estimates suggest that the blistering growth will continue through 2027.

Image Source: Zacks Investment Research

Additionally, several Wall Street analysts tracked by Zacks have upped estimates, helping the stock earn a best possible Strong Buy rating.

Image Source: Zacks Investment Research

COHR, LITE Score the Coveted NVIDIA Investment NVIDIA is not only the largest company in the world by market cap; it’s also the undisputed AI leader.  Earlier this month, NVIDIA announced it will invest $2 billion each in photonic product makers Lumentum and Coherent. Beyond the cash injection, the investment underscores the importance of photonics in the growing AI ecosystem.

Photonics: Industry Tailwinds & Powerful Price ActionOne of the best signs for investors occurs when multiple stocks in an industry rise in concert. The photonics industry is doing just that. Meanwhile, savvy investors understand that latching onto existing trends is often more optimal than searching for bargains. In other words, the easiest way for an investor to find the next stock to double is to look what already has. Each photonics stock has displayed extreme relative strength compared to the broader market. COHR has gained 529%, LITE has gained 1,152%, and AAOI has gained a staggering 3,433% over the past three years.

Image Source: Zacks Investment Research

AAOI: Power & Distance are CorrelatedOne of the most valuable lessons I learned while working for legendary growth investor William O’Neil is that “What often seems too high moves higher.”  Following its earnings report, AAOI shares bolted 57% as volume turnover swelled to 359% above the 50-day norm.

Image Source: TradingView

Remember, power and distance are correlated. The robust price action in photonics stocks suggests that the move is still likely in its infancy. I would be a buyer of these names on pullbacks and consolidations.

4.2K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Key Takeaways EGY finished drilling the ET-14P exploration well, but it encountered a water-bearing reservoir.VAALCO found about 10 meters of Gamba sands, aligned with the pre-drill geological expectations.EGY plans to drill the ET-14H development well toward a proven Etame area, with completion expected in April. VAALCO Energy (EGY - Free Report) , an independent exploration and production company, has recently finished drilling the ET-14P exploration well at the Etame field, which was part of its Phase Three drilling program. The exploration well, located offshore Gabon, encountered approximately 10 meters of high-quality Gamba sands. The results from the exploration program aligned with the pre-drill geological expectations.

The company has reported that the target zone of the reservoir turned out to be water-bearing. Since no hydrocarbons were found in the exploration well, VAALCO has decided that the lower part of the well will be plugged and abandoned. The company has stated that it will drill the ET-14H development well from the existing wellbore. The development well will be drilled in the Main Fault Block of Etame, but this plan is still pending approval from the partners.

VAALCO has mentioned that management was aware that the Etame West exploration well might not be commercially successful or encounter commercially viable quantities of hydrocarbons. The size of the reservoir made it a risk worth taking. Additionally, the company had planned for the negative outcome and designed the well so that a development well could be drilled using the same wellbore. This should enable the company to drill toward a different target. In this case, the company intends to drill the development well toward the proven productive area of the field. The drilling operations associated with the development well are anticipated to be completed in April.

EGY’s Zacks Rank and Key PicksEGY currently has a Zacks Rank #5 (Strong Sell).

Some better-ranked stocks from the energy sector are Archrock Inc. (AROC - Free Report) , Subsea7 (SUBCY - Free Report) and Galp Energia (GLPEY - Free Report) . While Archrock sports a Zacks Rank #1 (Strong Buy), Subsea7 and Galp Energia carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

Archrock is an energy infrastructure company based in the United States with a focus on midstream natural gas compression. It provides natural gas contract compression services and generates stable fee-based revenues. With natural gas playing an increasingly important role in the energy transition journey, AROC is expected to witness sustained demand for its services.

Subsea7 helps build underwater oil and gas fields. It is a leading player in the global offshore energy industry, providing engineering, construction and related services at offshore oil and gas fields. The long-term outlook for energy demand remains positive, and Subsea7’s focus on cost-efficient deepwater projects strengthens the position of its subsea business.

Galp Energia is a Portuguese energy company engaged in exploration and production activities. The company’s oil exploration efforts have yielded positive results, particularly with the Mopane discovery in the Orange Basin, offshore Namibia. This discovery allows Galp to diversify its global presence with the potential to become a significant oil producer in the region.

HomeEarnings AnalysisTech 

SummaryBroadcom Inc. delivered record Q1 FY26 results, with revenue up 29% and strong beats on both top and bottom lines.AI semiconductor revenue surged 108% YoY to $8.4B, now 44% of total revenue, with a $73B AI chip backlog and line of sight to $100B AI revenue in 2027.AVGO management guided Q2 revenue to ~$22B, 47% YoY growth, and authorized a new $10B buyback, reaffirming a Strong Buy rating.Customer concentration and hyperscaler chip cycle transitions remain key risks, but AVGO’s sticky co-design model and robust backlog provide near-term resilience. Sundry Photography/iStock Editorial via Getty Images

Broadcom Inc. (AVGO) reported its first-quarter fiscal 2026 on March 4, 2026, with numbers that exceeded expectations. Revenue, for example, outpaced Wall Street estimates by 0.90%, while diluted EPS (non-GAAP) exceeded estimates by 1.32%

3.3K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of AMZN, MSFT, GOOGL, META either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Strategy Today

$141.76 +2.81 (+2.02%)

As of 12:26 PM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$104.17▼

$457.22Price Target$368.21

In a climate of investor uncertainty and choppy market sessions, Strategy Inc. NASDAQ: MSTR has delivered a powerful statement of its corporate mission.

The enterprise software and Bitcoin development company recently finalized another major acquisition, purchasing nearly 18,000 bitcoins as part of an aggressive execution of a core business strategy that sets Strategy apart in the public markets.

By continuing its relentless accumulation, Strategy reinforces its unique identity as a purpose-built vehicle for acquiring Bitcoin, offering a compelling, distinct proposition for investors.

Get Strategy alerts:

Breaking Down the Billion-Dollar Buy The scale of Strategy's latest move is best understood through the specifics of the transaction. Between March 2 and March 9, 2026, the firm acquired 17,994 bitcoins for a total cash outlay of approximately $1.28 billion. This purchase was conducted at an average price of $70,946 per coin, a strategic entry during a period of notable market volatility.

This substantial investment was financed through the company’s sophisticated at-the-market (ATM) capital-raising programs. The capital was sourced from two primary channels: the sale of MSTR common stock, which generated $899.5 million in net proceeds, and the issuance of its preferred stock, a Digital Credit instrument that contributed another $377.1 million. This highlights the effectiveness of Strategy's dual-engine approach to raising capital for the express purpose of expanding its Bitcoin treasury.

Following this latest acquisition, the firm's total holdings have grown to a formidable 738,731 bitcoins. The entire treasury was acquired at an aggregate cost of $56.04 billion, resulting in an average purchase price of $75,862 per bitcoin across its holdings.

Engineering a Bitcoin Yield for Shareholders For investors seeking exposure to the digital asset space, Strategy Inc. offers a value proposition that differs fundamentally from directly purchasing Bitcoin. Strategy Inc. is intentionally structured to provide amplified, or leveraged, exposure to the cryptocurrency. By leveraging its access to equity and credit markets to raise capital, Strategy can acquire Bitcoin at a scale and pace far beyond what its operational cash flow alone would allow. This leverage means that during periods of Bitcoin price appreciation, the potential for shareholder returns can be significantly magnified compared to the underlying asset.

A core metric for understanding this value creation is Bitcoin Per Share (BPS). Management’s stated objective is to consistently increase this figure over time. When Strategy successfully raises capital and acquires Bitcoin in a manner that increases the amount of BTC attributable to each outstanding share, it effectively generates a BTC Yield for its investors. Over time, each share of Strategy stock aims to represent a growing fraction of the underlying digital asset, a dynamic that direct ownership cannot replicate.

This unique model is a primary reason the stock often trades at a premium, where its market capitalization exceeds the direct market value of its Bitcoin holdings. This premium is a critical indicator of investor confidence. It signals that market participants place a tangible value on the firm’s operational strategy, the leadership of Executive Chairman Michael Saylor, and its proven ability to raise and deploy capital accretively. In essence, the premium reflects a belief that Strategy's active, leveraged approach will create more value in the long run than a passive holding strategy.

The Strength of a Dual-Pronged Enterprise While a leveraged strategy in a volatile asset class naturally involves risk, Strategy Inc. has deliberately engineered its corporate and financial structure to provide long-term durability and weather market cycles. This structure rests on several key pillars designed to insulate the firm from short-term price volatility.

Strategy Stock Forecast Today12-Month Stock Price Forecast:
$368.21
162.73% Upside

Moderate Buy
Based on 17 Analyst Ratings

Current Price$140.15High Forecast$705.00Average Forecast$368.21Low Forecast$54.00Strategy Stock Forecast Details

A Substantial Cash Reserve: Strategy maintains a dedicated $2.25 billion USD cash reserve. This fund is explicitly earmarked to cover over two and a half years of all debt service payments and preferred stock dividend obligations, ensuring Strategy can meet its financial commitments without being forced to liquidate its Bitcoin holdings during unfavorable market conditions. A De-Risked Balance Sheet: Strategy’s financial health is a point of emphasis. Its net leverage remains low relative to S&P 500 sector averages, and its debt is intentionally structured with staggered, long-term maturities. This approach prevents near-term liquidity crunches and provides a multi-year runway for its strategy to unfold. A Profitable Software Foundation: Underpinning the entire Bitcoin strategy is a stable and cash-flow-positive enterprise. Strategy's established software business remains a strong performer, providing a consistent source of revenue. In its Q4 2025 results, Strategy reported a 1.9% year-over-year increase in total revenue, which was bolstered by a 62.1% surge in its high-margin subscription services. This profitable operating business provides a financial bedrock that is distinct from the Bitcoin treasury. A Pioneer Forging a Digital Path Strategy Inc.’s latest billion-dollar Bitcoin purchase is an unambiguous reaffirmation of its commitment to a pioneering corporate mission. The move demonstrates a clear, long-term vision being executed with consistent, disciplined action in the capital markets.

For investors, Strategy Inc. has been meticulously structured as a high-conviction instrument. It offers a professionally managed, leveraged vehicle for participating in the potential of digital assets, all while being anchored by a sound operating business and a balance sheet fortified against volatility. For investors who share a bullish, long-term outlook for Bitcoin and appreciate a strategic, leveraged approach, Strategy Inc. offers a compelling, unique way to invest in Bitcoin's growth.

Should You Invest $1,000 in Strategy Right Now?Before you consider Strategy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Strategy wasn't on the list.

While Strategy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ultragenyx To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Ultragenyx between August 3, 2023 and December 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - March 10, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ultragenyx Pharmaceutical Inc ("Ultragenyx" or the "Company") (NASDAQ: RARE) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to the effects of setrusumab on patients with variable types of Osteogenesis Imperfecta ("OI"), while also minimizing risk that patients in Ultragenyx' Phase III Orbit study would fail to achieve a statistically significant reduction in annualized fracture rate ("AFR"), such that the second interim analysis could be performed and presented to the investing public; and (ii) in truth, Ultragenyx' optimism in the Phase III Orbit study's results and interim analysis benchmark were misplaced because Ultragenyx failed to convey the risk associated with basing such threshold figures on Phase II results that had no placebo control group for appropriate comparison and thus had not ruled out that the reduction in AFR from that study could merely be triggered by an increased standard of care and the placebo effect of being provided a novel treatment.

On July 9, 2025, Ultragenyx revealed that the Phase III Orbit study failed to achieve statistical significance for the second interim analysis and that Phase III Orbit and Cosmic studies would now be "progressing toward final analysis."

On this news, the price of Ultragenyx stock fell more than 25%, according to the complaint.

Then, on December 29, 2025, Ultragenyx announced that both its Phase III Orbit and Cosmic Studies had not "achieved statistical significance against the primary endpoints of reduction in annualized clinical fracture rate compared to placebo or bisphosphonates, respectively." Ultragenyx allegedly attributed the study failure to a "low fracture rate in the placebo group" of Orbit and a trend that fell shy of statistical significance in Cosmic.

On this news, the price of Ultragenyx stock fell more than 42%, according to the complaint.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Ultragenyx's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Ultragenyx Pharmaceutical class action, go to www.faruqilaw.com/RARE or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/287962

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

4.51K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

AXON jumps nearly 29% in a month on strong device and software demand, but high valuation and rising costs may prompt investors to wait.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© wWeiss Lichtspiele / iStock via Getty Images

Intel (NASDAQ: INTC) may be one of the most recognized names in technology, but the stock’s dramatic run from near $24 a year ago to about $46 today has outpaced underlying reality. Short sellers appear to agree. The latest short interest data shows another increase, and the stock remains the most shorted Dow Jones industrial.

The Bull Case Lacks Credibility Bulls point to real positives: Nvidia (NASDAQ: NVDA | NVDA Price Prediction) invested $5 billion in Intel common stock, government backing and $8.9 billion in CHIPS Act funding, and Data Center & AI segment growth of 9% year-over-year in Q4. The turnaround narrative is compelling on the surface. Yet, it just doesn’t justify the valuation or mask what is structurally broken.

Why to Bet Against: The Core Thesis The foundry is a cash furnace. Intel Foundry lost $2.51 billion in Q4 alone, and cumulative foundry operating losses across all four quarters of 2025 totaled roughly $10.3 billion. Revenue is growing, but losses aren’t narrowing meaningfully. CEO Lip-Bu Tan acknowledged on the earnings call: “While yields are in line with our internal plans, they are still below what I want them to be.” That’s not a ringing endorsement of execution.

The core business is shrinking. The Client Computing Group (roughly 60% of revenue) declined 7% year-over-year in Q4 and was down in three of four quarters in 2025. Advanced Micro Devices’ (NASDAQ: AMD) client segment, by contrast, surged 34% year-over-year in Q4 2025. Market share is moving away from Intel.

The guidance is alarming. For Q1 2026, Intel guided revenue of $11.7 billion to $12.7 billion, which would be a significant sequential decline from Q4’s $13.67 billion. And it guided non-GAAP EPS of $0.00 and a GAAP loss of $0.21. Supply is expected to be at its tightest in Q1. This isn’t a growth story.

The valuation doesn’t fit the fundamentals. Intel trades at 85 times expected future earnings while posting a full-year net loss of $267 million. Intel’s CFO disposed of over 49,000 shares of common stock on March 2 alone at $44.88 per share. So, insiders appear to see the stock as fairly valued at best.

What Could Prove the Thesis Wrong It might be worth reconsidering if Intel 18A yields scale faster than expected and attracts a major external foundry customer. The CEO noted firm supplier decisions could come starting in the second half of 2026. A meaningful DCAI revenue acceleration or strategic acquisition could also shift the thesis. Q2 2026 earnings will be the first real test of whether supply constraints ease as promised.

The Bottom Line Conviction here is a 7 out of 10. Intel is not uninvestable forever, but at current prices (with analyst consensus sitting at Hold/Reduce and an average target of $47.11) the risk-reward skews bearish. Investors looking to reallocate might find AMD’s 34% revenue growth and $5.5 billion in annual free cash flow a more compelling semiconductor story right now.

ATLANTA, March 10, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Driven Brands Holdings Inc. (“Driven Brands” or the “Company”) (NASDAQ: DRVN). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts in the Company’s financial statements from fiscal 2023 through the quarter ended September 27, 2025.

If you purchased Driven Brands’ shares between May 9, 2023, and February 24, 2026, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/driven-brands/ for more information.

The deadline to ask the court to be appointed lead plaintiff in the case is May 8, 2026.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]

March 10, 2026 11:19 ET  | Source: Talisker Resources Ltd.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES
OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO, March 10, 2026 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased to announce the closing of its previously announced “bought deal” private placement (the “Offering”) for gross proceeds of C$52,100,000 from the sale of 26,000,000 units of the Company (the “Units”) at a price of $2.00 per Unit (the “Offering Price”) and a partial exercise of the over-allotment option (the “Over Allotment Option”) for 625,000 common share purchase warrants of the Company (each, a “Warrant”). Red Cloud Securities Inc. (“Red Cloud”) acted as lead underwriter and sole bookrunner on behalf of itself and A.G.P. Canada Investments ULC, the other member of the syndicate (collectively with Red Cloud, the “Underwriters”). All amounts are in Canadian dollars unless otherwise noted.

Each Unit consists of one common share of the Company (each, a “Common Share”) and one-half of one Warrant. Each whole Warrant entitles the holder to purchase one Common Share at a price of $2.70 at any time on or before March 10, 2028. The Company will use reasonable commercial efforts to list the Warrants for trading on the Toronto Stock Exchange (the “TSX”).

The Company intends to use the net proceeds from the Offering for the continued advancement of the Company’s flagship Bralorne Gold Project in British Columbia, as well as for general corporate purposes and working capital.

In accordance with National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”), 5,071,431 Units were issued to Canadian purchasers pursuant to the “listed issuer financing” exemption under Part 5A of NI 45-106, as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the “Listed Issuer Financing Exemption”). The remaining Units sold under the Offering were issued (i) on a private placement basis pursuant to exemption from the prospects requirements in Canada under NI 45-106 and (ii) in offshore jurisdictions to purchasers outside of Canada pursuant to an exemption from the prospectus requirements in Canada available under OSC Rule 72-503. The securities issuable from Units sold to Canadian purchasers pursuant to the Listed Issuer Financing Exemption are immediately freely tradeable in accordance with applicable Canadian securities legislation, while the Common Shares and Warrants issuable from the sale of Units under other prospectus exemptions in Canada are subject to a four month hold period.

Certain insiders of the Company subscribed for Units pursuant to the Offering. Participation by such insiders in the Offering was considered a “related party transaction” pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company was exempt from the requirements to obtain a formal valuation or minority shareholder approval in connection with such insiders’ participation in the Offering in reliance on Sections 5.5(a) and 5.7(1)(a) of MI 61-101. A material change report in connection with the Offering will be filed less than 21 days in advance of the closing of the Offering, which the Company deemed reasonable in the circumstances so as to be able to avail itself of potential financing opportunities and complete the Offering in an expeditious manner.

There is an amended and restated offering document (the “Amended Offering Document”) related to the Offering that can be accessed under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.taliskerresources.com.

The closing of the Offering remains subject to the final approval of the TSX.

This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

For further information, please contact:

Lindsay Dunlop
Vice President, Investor Relations
[email protected]
+1 647 274 8975

About Talisker Resources Ltd.

Talisker (taliskerresources.com) is a junior resource company involved in the exploration and development of gold projects in British Columbia, Canada. Talisker’s flagship asset is the high-grade, fully permitted Bralorne Gold Project where the Company is producing at the Mustang Mine. Talisker projects also include the Ladner Gold Project, an advanced stage project with significant exploration potential from an historical high-grade producing gold mine and the Spences Bridge Project where the Company has a significant landholding in the emerging Spences Bridge Gold Belt, and several other early-stage Greenfields projects.

Caution Regarding Forward Looking Statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Talisker’s current belief or assumptions as to the outcome and timing of such future events. In particular, this press release contains forward-looking information relating to, among other things, the intended use of proceeds from the Offering, Talisker’s intention to list the Warrants for trading on the TSX, and the final approval of the Offering from the TSX. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to Talisker. Although such statements are based on reasonable assumptions of Talisker’s management, there can be no assurance that any conclusions or forecasts will prove to be accurate.

Forward looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include risks inherent in the exploration and development of mineral deposits, including risks relating to changes in project parameters as plans continue to be redefined, risks relating to variations in grade or recovery rates, risks relating to changes in mineral prices and the worldwide demand for and supply of minerals, risks related to increased competition and current global financial conditions, access and supply risks, reliance on key personnel, operational risks regulatory risks, including risks relating to the acquisition of the necessary licenses and permits, financing, capitalization and liquidity risks, title and environmental risks and risks relating to the failure to receive all requisite regulatory approvals.

The forward-looking information contained in this press release is made as of the date hereof, and Talisker is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

LOS ANGELES, March 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lakeland Industries, Inc. (“Lakeland” or “the Company”) (NASDAQ: LAKE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between December 1, 2023, and December 9, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before April 24, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Lakeland suffered from significant issues in multiple business units such as shipping delays, production problems, and slow product launches. The Company misled the market about the strength of its operations, particularly in the struggling business units including Pacific Helmets and Jolly. The Company overstated the effectiveness of its tariff mitigation strategy. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Lakeland, investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.        

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

The Schall Law Firm

Q4: 2026-03-03 Earnings SummaryEPS of $1.58 beats by $0.65

 |

Revenue of

$108.25M

(151.08% Y/Y)

beats by $21.16M

AnaptysBio, Inc. (ANAB) Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:30 AM EDT

Company Participants

Daniel Faga - President, CEO & Director

Conference Call Participants

Etzer Darout - Barclays Bank PLC, Research Division

Presentation

Etzer Darout
Barclays Bank PLC, Research Division

Hello again, everyone. I'm Etzer Darout, senior biotech analyst at Barclays. My pleasure to have AnaptysBio CEO, Dan Faga, with us this morning. And maybe just to kick us off, Dan, if you could just give us an overview of AnaptysBio for those less familiar with the story.

Daniel Faga
President, CEO & Director

Perfect. We're in exciting times right now. We're approximately a month or 2 out from creating a second company called First Tracks Bio, which will be the biopharma operations from Anaptys that we're spinning off. Anaptys has been around for over 20 years, developing antibodies. We have 2 successful programs so far out of our platform, one Jemperli dostarlimab, which is being sold by GSK, it's an oncology drug PD-1 antagonist.

And the second has a PDUFA date at the end of the year. It's called imsidolimab for GPPs, which hopefully will be sold at the end of this year by a company called Vanda. Those 2 programs will stay behind, forming a royalty-based financial company that will retain the name AnaptysBio. In the biopharma business, we have a couple of exciting programs. One is AMB033, CD122 antagonist. It's being developed in celiac disease as well as EoE Phase Ib. We have rosnilimab, which is a PD-1 depleter. We had positive Phase IIb data in arthritis this past year. And currently, we are assessing how best to move that program forward into Phase III.

We're meeting with the FDA this quarter, and we'll be looking for strategic or other financial capital to further

Key Takeaways OKLO and LEU plan a joint venture to develop HALEU deconversion services for advanced nuclear reactor fuel.OKLO seeks to secure a reliable nuclear fuel supply as it develops fast fission plants for carbon-free energy.LEU's Piketon site is being explored for the facility, near OKLO's planned 1.2-GW campus tied to a Meta deal. Oklo Inc. (OKLO - Free Report) and Centrus Energy Corp. (LEU - Free Report) plan to pursue a joint venture focused on deconversion services for high-assay low-enriched uranium (HALEU), a critical fuel for advanced nuclear reactors. Deconversion converts enriched uranium into chemical forms such as oxide or metal that can be fabricated into reactor fuel. The collaboration is designed to strengthen the domestic nuclear fuel supply chain by pairing OKLO’s advanced reactor development with Centrus’ expertise in uranium enrichment and nuclear fuel services. By focusing on this key middle step in the fuel cycle, the companies aim to strengthen fuel availability and support the wider deployment of next-generation nuclear reactors in the United States.

OKLO is developing fast fission power plants designed to deliver scalable, carbon-free energy. For such reactors to operate reliably, developers must secure dependable access to nuclear fuel at multiple stages of the production cycle. Company leadership has emphasized that building advanced reactors alone is not sufficient. Long-term success requires a robust infrastructure capable of supporting enrichment, deconversion and fuel fabrication. This partnership reflects that strategy by looking for ways to expand U.S. fuel-cycle capacity and build a more connected system for supplying fuel to advanced nuclear reactors.

The companies plan to explore locating the facility at Centrus’ site in Piketon, OH, where enrichment operations are already underway. The proposed project would be positioned next to these operations and adjacent to OKLO’s planned 1.2-gigawatt power campus. Notably, the campus has gained momentum after a major agreement with Meta Platforms (META - Free Report) to support future data center power needs. Under the arrangement, META is helping fund early development work, and META’s long-term electricity demand is expected to anchor the project. The partnership with META also provides clearer demand visibility as OKLO advances construction plans.

Co-locating enrichment and deconversion could reduce transportation needs and simplify the movement of HALEU between processing stages. The concept also has broader implications for the nuclear industry. A centralized deconversion hub could allow multiple advanced reactor developers to access specialized fuel services without building their own facilities, helping expand domestic nuclear fuel capacity and supporting the wider deployment of advanced reactors in the United States.

The Zacks Rundown on OKLOShares of Oklo have surged more than 160% over the past year, breezing past the industry's growth.

Image Source: Zacks Investment Research

OKLO currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 20 brokerage firms. 

Image Source: Zacks Investment Research

See how the Zacks Consensus Estimate for OKLO’s earnings has been revised over the past 90 days.

Image Source: Zacks Investment Research

The company currently carries a Zacks Rank #4 (Sell). 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways American Public Education's Q4 revenues are expected at $150M-$153.5M, down 6-9% YoY due to APUS weakness.APEI likely saw APUS registrations fall 23-33%, impacted by the government shutdown.APEI may benefit from steady enrollment growth at Rasmussen University and Hondros College of Nursing. American Public Education, Inc. (APEI - Free Report) is scheduled to report its fourth-quarter 2025 results on March 12, after market close.

In the last reported quarter, the company's adjusted earnings and total revenues topped the Zacks Consensus Estimate and grew year over year.

American Public Education’s earnings topped the consensus mark in each of the trailing four quarters, the average surprise being 173.7%.

How Are Estimates Placed for APEI Stock?For the fourth quarter, the Zacks Consensus Estimate of adjusted loss per share has remained unchanged at 39 cents over the past 30 days. The estimated figure indicates a 38.1% year-over-year decline from adjusted EPS of 63 cents.

The consensus estimate for revenues is pegged at $151.8 million, indicating a 7.5% decrease from $164.1 million reported in the year-ago quarter.

Factors Likely to Define American Public Education’s Q4 ResultsRevenuesAmerican Public Education’s fourth-quarter top-line is expected to have decreased due to weaker activity in the American Public University System (“APUS”) segment and a sharp decline in course registrations tied to disruptions in military tuition assistance processing.

For the quarter to be reported, American Public Education expects net course registrations in the APUS segment (which accounted for 50.9% of total third-quarter 2025 revenues) to be down year over year by 23-33% between 65,000 and 74,400. The decline is largely linked to the government shutdown that slowed military tuition assistance approvals and muted enrollments during October and November. The disruption reduced registrations from service members who rely on tuition assistance benefits to fund education programs.

The company expects fourth-quarter consolidated revenues to be between $150 million and $153.5 million, indicating a year-over-year decline of 6-9%.

Our model expects net course registrations in the APUS segment to be down year over year by 28.5% to 69,412.

Despite the near-term pressure, enrollment growth at Rasmussen University (37.3%) and Hondros College of Nursing (11.3%) remains steady. Healthcare education demand and expanding enrollments in nursing programs have been supporting growth in these segments and might have helped partially offset weakness in APUS over the long term.

Enrollments are expected to increase year over year by 9% to 15,900 and 9% to 4,000 in the RU and the HCN segments, respectively. Under the RU segment, APEI expects on-ground healthcare enrollments to grow 13% year over year to 7,100 and online enrollments to increase 6% to 8,800.

EarningsThe bottom-line performance of American Public Education is likely to have been affected by higher spending related to marketing and operational activities during the quarter. The company has continued to invest in advertising and enrollment-focused initiatives to support student acquisition efforts across its education units. These spending efforts are expected to have increased operating expenses and limited profitability.

For the fourth quarter, APEI expects to report earnings per share between 32 cents and 45 cents. Adjusted EBITDA is expected to be between $18.5 million and $22 million compared with $21 million.

Our model expects adjusted EBITDA to be down year over year by 33.4% to $20.9 million.

What the Zacks Model Says About American Public EducationOur proven model does not conclusively predict an earnings beat for American Public Education this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. Unfortunately, this is not the case here, as you will see below.

Earnings ESP: APEI has an Earnings ESP of 0.00%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.

Zacks Rank: APEI currently sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Stocks Poised to Beat Earnings EstimatesHere are some stocks from the Zacks Consumer Discretionary sector that investors may consider, as our model indicates they have the right combination of elements to post an earnings beat.

Cintas Corporation (CTAS - Free Report) currently has an Earnings ESP of +0.80% and a Zacks Rank of 3.

CTAS’ earnings beat estimates in each of the past four quarters, the average surprise being 3%. Cintas’ earnings for the fourth quarter of 2025 are expected to increase 8.9% year over year.

Boyd Gaming (BYD - Free Report) has an Earnings ESP of +4.44% and a Zacks Rank #3 at present.

BYD reported better-than-expected earnings in each of the trailing four quarters, the average surprise being negative 11.4%. Boyd Gaming’s earnings for the to-be-reported quarter are expected to increase 8%.

Lifetime Brands, Inc. (LCUT - Free Report) presently has an Earnings ESP of +37.93% and a Zacks Rank of 3.

LCUT’s earnings beat estimates in two of the past four quarters and missed on the remaining two occasions, the negative average surprise being 60.1%. Lifetime Brands’ earnings for the fourth quarter of 2025 are expected to decline 47.3% year over year.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another.

Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a technical analyst for Dow Jones Newswires and as the senior market analyst with TraderPlanet.com. Jim is also a consultant with the highly respected "Pro Farmer" agricultural advisory service. Jim was also the head equities analyst at CapitalistEdge.com. He received his degree from Iowa State University in Ames, Iowa, where he studied journalism and economics.

Follow Jim daily on Kitco.com as he provides both AM and PM roundups and a daily Technical Special. 1 877 963-NEWS jwyckoff at kitco.com

BAC is down 12.9% YTD, but NII growth targets, branch expansion and a $40 billion buyback raise the stakes on whether this dip is worth buying.

Key Takeaways Terreno Realty sold a 56,000-sq-ft fully leased industrial property in Lanham, MD for $11.1M on March 6, 2026.Terreno Realty bought the asset in Dec 2013 for $5.6M, generating a 10.8% unleveraged internal rate of return.TRNO sold $386.4M of properties in 2025 and had $19.9M of dispositions under contract as of Dec. 31, 2025. Terreno Realty Corporation (TRNO - Free Report) announced the disposition of an industrial property located in Lanham, MD. The sale was carried out on March 6, 2026, for approximately $11.1 million.

The property spans across 56,000 square feet, comprising a light industrial building on 4.5 acres, 100% leased. Terreno Realty had purchased the property on Dec. 11, 2013, for $5.6 million. The investment yielded an unleveraged internal rate of return of 10.8% to the company.

Terreno Realty’s dispositions are an integral part of its ongoing efforts to optimize its portfolio and enhance its financial performance. In the fourth quarter of 2025, the company sold properties worth $144.2 million.

Total dispositions for the year 2025 aggregated $386.4 million. As of Dec. 31, 2025, the company has dispositions under contract to the tune of $19.9 million, subject to completion of due diligence and closing conditions.

Wrapping Up on TRNOBy selling a potentially non-core or mature asset,  Terreno can redeploy the proceeds into acquisitions or development projects in stronger industrial markets that offer higher growth prospects. The transaction may also enhance the company’s liquidity and financial flexibility, enabling it to fund future investments or manage its balance sheet more efficiently. While the sale could lead to a slight near-term decline in rental income if the asset was contributing to revenues, reinvestment of the proceeds into higher-yielding opportunities is expected to support long-term earnings growth.

Over the past six months, shares of this Zacks Rank #2 (Buy) company have risen 6.8% compared with the industry's growth of 4.1%. Analysts seem bullish on this industrial REIT, with its 2026 FFO per share estimate moving northward 1.1% over the past month to $2.79.

Image Source: Zacks Investment Research

Other Stocks to ConsiderSome other top-ranked stocks from the broader REIT sector are Chatham Lodging Trust REIT (CLDT - Free Report) , sporting Rank #1 (Strong Buy) and Cousins Properties (CUZ - Free Report) , carrying Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for CLDT’s 2026 FFO per share is pegged at $1.20, which indicates year-over-year growth of 17.7%.

The Zacks Consensus Estimate for CUZ’s full-year FFO per share is pinned at $2.93, which calls for an increase of 3.2% from the year-ago period.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO) — a widely used metric to gauge the performance of REITs.

Babylon Labs has partnered with hardware wallet maker Ledger to expand access to its trustless Bitcoin vault infrastructure, aiming to make native bitcoin more usable in decentralized finance while preserving self-custody.

The integration introduces native Ledger signer support for Babylon’s Trustless Bitcoin Vaults, known as BTCVaults, allowing users to authorize vault transactions directly from a Ledger device using the company’s Clear Signing interface, according to an announcement.

BTCVaults are designed to let bitcoin holders deploy their assets as collateral in decentralized financial applications without relying on custodians, bridges, or wrapped tokens. Instead, the assets remain on the Bitcoin network and are governed by programmable conditions that can be verified onchain.

Babylon co-founder David Tse said the goal is to remove a longstanding limitation in the crypto economy. “Bitcoin is the largest crypto asset, yet most of it cannot be used in digital finance without giving up custody or relying on intermediaries,” Tse said. “Trustless Bitcoin Vaults remove that trade-off. Bitcoin stays on Bitcoin, governed by predefined conditions that are verified rather than trusted.”

Ledger will serve as the secure signing layer for vault interactions, meaning users can confirm and approve transactions directly on their hardware device rather than through a browser or wallet interface.

A key feature of the integration is Ledger’s Clear Signing system, which displays the full details of a transaction on the device’s screen before approval, allowing users to verify exactly what they are authorizing. Ledger Chief Technology Officer Charles Guillemet said the approach aligns with the company’s core philosophy around digital asset ownership.

“If not self-custody, why crypto?” Guillemet said. “True self-custody relies on uncompromising security. Now, Babylon BTCVaults users can use secure signers featuring a dedicated screen as part of their security model.”

The collaboration also broadens Babylon’s presence across the Ledger ecosystem, including connectivity through the Ledger Wallet application and support for Babylon’s native token BABY.

Babylon and bitcoin Babylon Labs focuses on what it calls “trustless Bitcoin productivity,” building tools that allow bitcoin to secure other blockchain systems and participate in decentralized finance while remaining on the Bitcoin network.

The project already launched a self-custodial bitcoin staking protocol, which it says has activated more than $10 billion worth of native BTC to secure proof-of-stake chains, Layer 2 networks, and other decentralized systems.

Partnering with the hardware wallet makers adds to Babylon’s growing ecosystem and institutional backing. Venture firm a16z Crypto previously purchased $15 million worth of BABY tokens to support the development of BTCVaults and related infrastructure.

Babylon’s technology has also been adopted by industry platforms seeking to offer bitcoin yield without traditional lending or wrapping mechanisms. Crypto exchange Kraken, for example, introduced bitcoin staking through Babylon last year, allowing users to earn rewards while retaining custody of their BTC.

Ledger has simultaneously expanded its own push into bitcoin-native financial tools. The company recently rolled out a BTC yield feature in Ledger Wallet, developed with partners Lombard and Figment, to give hardware wallet users access to yield-generating strategies while maintaining hardware-level security.

Disclaimer: The Block is an independent media outlet that delivers news, research, and data. As of November 2023, Foresight Ventures is a majority investor of The Block. Foresight Ventures invests in other companies in the crypto space. Crypto exchange Bitget is an anchor LP for Foresight Ventures. The Block continues to operate independently to deliver objective, impactful, and timely information about the crypto industry. Here are our current financial disclosures.

© 2026 The Block. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Cover image via U.Today Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Shiba Inu is approaching a critical moment as on-chain metrics and price behavior converge around a key supply threshold. The amount of SHIB held on exchanges is currently hovering near 80 trillion tokens, a level that could play an important role in determining the asset’s next move. While the price has managed to stabilize slightly in recent sessions, the broader market structure surrounding SHIB remains fragile.

Shiba Inu locked in downtrendOver the past several months, Shiba Inu has been locked in a steady downtrend. The chart shows a series of lower highs and repeated breakdowns from consolidation patterns, indicating persistent selling pressure. 

SHIB/USDT Chart by TradingViewSHIB is currently trading near the $0.0000057 range, where short-term stabilization has appeared after another leg lower. However, the recovery attempts remain limited and continue to struggle against declining resistance levels.

HOT Stories

Despite the weak price structure, on-chain data shows that substantial outflows from exchanges have been occurring. A negative exchange flow environment generally means that tokens are being moved off trading platforms into private wallets. 

Longer-term effect This behavior can sometimes reflect accumulation or longer-term holding, as fewer tokens remain available for immediate selling on exchanges.

You Might Also Like

At the same time, network activity remains relatively steady. Both the mean transfer count and total transfer count have increased slightly, suggesting that the Shiba Inu network is still seeing consistent usage. Increased transaction activity can indicate ongoing participation in the ecosystem even while the price remains under pressure.

The key factor now centers around the 80 trillion SHIB exchange reserve threshold. If reserves fall decisively below this level, it would signal that a significant portion of supply has been removed from exchanges. 

That kind of shift can tighten circulating liquidity and occasionally create the conditions for stronger price rebounds.

However, the opposite scenario carries risk. If selling pressure returns and the market pushes reserves higher again while the price breaks lower, the current stabilization phase could quickly unravel. A loss of the nearby support zone on the chart would likely open the path toward another decline.

Bitcoin is trading at $70,426 per unit on March 10, 2026, after rebounding from an intraday low of $67,958 and briefly testing a session high of $71,220. The cryptocurrency's market capitalization stood at $1.408 trillion with $54.48 billion in 24-hour trading volume as price action stabilized within a well-defined intraday range.

In brief Attackers allegedly posed as police officers to enter a home near Versailles. A couple were threatened at knifepoint and forced to transfer about €900,000 ($1 million) in Bitcoin. French authorities have confirmed the crypto loss and launched a manhunt. Authorities in the Versailles area are searching for three suspects after a home invasion in which attackers allegedly posed as police and stole crypto.

A couple in their late 50s were forced to transfer roughly €900,000 (about $1 million) in Bitcoin after three men posing as police entered their home in Le Chesnay, near Versailles, according to French broadcaster TF1.

The suspects allegedly gained entry by identifying themselves as police officers before pulling a knife and threatening to stab the woman unless her partner sent Bitcoin to a wallet they controlled, TF1 reported, citing sources close to the investigation.

The Versailles public prosecutor’s office has confirmed the crypto theft, according to local reporting, and said the case is being handled by France’s Brigade for the Repression of Banditry (BRB). No arrests had been announced at time of publication, with potential charges reportedly including kidnapping, armed robbery, organized crime, and criminal conspiracy.

Wrench attacks in FranceThe robbery fits an expanding pattern of “$5 wrench attacks,” where criminals use physical coercion rather than technical compromise to seize digital assets. These cases have become a growing security concern for crypto holders as victims are targeted at home, often after criminals have identified likely victims through public signals, leaks, or social engineering.

France has become a hotbed of “wrench attacks,” which have included violent home invasions targeting crypto executives, crypto ransom demands and the abduction and mutilation of Ledger CEO David Balland. Last May, French police arrested 12 suspects linked to crypto kidnapping probes—but the crime wave shows no signs of stopping.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.